On May 27, AdvaMed submitted a letter to Medicare Administrative Contractors (MACs), Novitas and First Coast Service Options, regarding proposed local coverage determinations (LCD) entitled “Skin Substitutes for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcer.” AdvaMed’s input focused on a number of issues within the LCD and the corresponding billing and coding guidelines including the classification of skin substitutes; the general scope of the policy; the limitation of no more than two applications of a skin substitute graft product; and billing and coding guidelines.
For more information on AdvaMed’s efforts around skin substitute products, please contact Tara Burke.